213 related articles for article (PubMed ID: 19634693)
21. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus DNA quantification with the three-in-one (3io) method allows accurate single-step differentiation of total HBV DNA and cccDNA in biopsy-size liver samples.
Taranta A; Tien Sy B; Zacher BJ; Rogalska-Taranta M; Manns MP; Bock CT; Wursthorn K
J Clin Virol; 2014 Aug; 60(4):354-60. PubMed ID: 24890819
[TBL] [Abstract][Full Text] [Related]
23. [Quantitative analysis of HBV cccDNA from liver biopsy specimens in HBV carriers: correlation with serological makers and sera HBV DNA].
Zhang L; Wu F; Shi LL; Dou XG
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):112-3. PubMed ID: 21863632
[TBL] [Abstract][Full Text] [Related]
24. CccDNA persistence during natural evolution of chronic VHB infection.
Caruntu FA; Molagic V
Rom J Gastroenterol; 2005 Dec; 14(4):373-7. PubMed ID: 16400354
[TBL] [Abstract][Full Text] [Related]
25. Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients.
Mazet-Wagner AA; Baclet MC; Loustaud-Ratti V; Denis F; Alain S
J Virol Methods; 2006 Dec; 138(1-2):70-9. PubMed ID: 16962180
[TBL] [Abstract][Full Text] [Related]
26. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
Nassal M
Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
[TBL] [Abstract][Full Text] [Related]
27. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication.
Guo Y; Li Y; Mu S; Zhang J; Yan Z
J Med Virol; 2009 Jul; 81(7):1177-83. PubMed ID: 19475606
[TBL] [Abstract][Full Text] [Related]
28. A sensitive and accurate quantification method for the detection of hepatitis B virus covalently closed circular DNA by the application of a droplet digital polymerase chain reaction amplification system.
Mu D; Yan L; Tang H; Liao Y
Biotechnol Lett; 2015 Oct; 37(10):2063-73. PubMed ID: 26187315
[TBL] [Abstract][Full Text] [Related]
29. [Dynamics of hepatitis B virus covalently closed circular DNA after serum virology response].
Li FF; Ren WH; Ding GH; Shi J; Han GQ
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):167-70. PubMed ID: 19335976
[TBL] [Abstract][Full Text] [Related]
30. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
[TBL] [Abstract][Full Text] [Related]
31. One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.
Wong DK; Yuen MF; Ngai VW; Fung J; Lai CL
Antivir Ther; 2006; 11(7):909-16. PubMed ID: 17302253
[TBL] [Abstract][Full Text] [Related]
32. Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication.
Takehara T; Suzuki T; Ohkawa K; Hosui A; Jinushi M; Miyagi T; Tatsumi T; Kanazawa Y; Hayashi N
J Hepatol; 2006 Feb; 44(2):267-74. PubMed ID: 16226822
[TBL] [Abstract][Full Text] [Related]
33. Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.
Lucifora J; Protzer U
J Hepatol; 2016 Apr; 64(1 Suppl):S41-S48. PubMed ID: 27084036
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.
Pollicino T; Belloni L; Raffa G; Pediconi N; Squadrito G; Raimondo G; Levrero M
Gastroenterology; 2006 Mar; 130(3):823-37. PubMed ID: 16530522
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.
Kumar R; Pérez-Del-Pulgar S; Testoni B; Lebossé F; Zoulim F
Liver Int; 2016 Jan; 36 Suppl 1():72-7. PubMed ID: 26725901
[TBL] [Abstract][Full Text] [Related]
36. Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).
Revill P; Locarnini S
Curr Opin Pharmacol; 2016 Oct; 30():144-150. PubMed ID: 27639371
[TBL] [Abstract][Full Text] [Related]
37. Enhanced specificity of real-time PCR for measurement of hepatitis B virus cccDNA using restriction endonuclease and plasmid-safe ATP-dependent DNase and selective primers.
Gao YT; Han T; Li Y; Yang B; Wang YJ; Wang FM; Jing X; Du Z
J Virol Methods; 2010 Oct; 169(1):181-7. PubMed ID: 20691734
[TBL] [Abstract][Full Text] [Related]
38. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.
Guo H; Jiang D; Zhou T; Cuconati A; Block TM; Guo JT
J Virol; 2007 Nov; 81(22):12472-84. PubMed ID: 17804499
[TBL] [Abstract][Full Text] [Related]
40. Replication and infectivity of hepatitis B virus in HBV-related glomerulonephritis.
Chen L; Wu C; Fan X; Gao J; Yin H; Wang T; Wu J; Wen SW
Int J Infect Dis; 2009 May; 13(3):394-8. PubMed ID: 19036623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
